Charles W. Stark - Jan 12, 2023 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
SVP, Clinical Development
Signature
Charles Stark
Stock symbol
EMMA
Transactions as of
Jan 12, 2023
Transactions value $
$450,000
Form type
4
Date filed
1/17/2023, 01:32 PM
Previous filing
Dec 28, 2021
Next filing
Feb 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EMMA Options Award $450K +100K $4.50* 100K Jan 12, 2023 Common Stock 100K $4.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as to one-third of the option shares on the 12-month anniversary of the grant date and as to the remaining two-thirds of the option shares in 24 equal monthly installments as of the end of each month after such anniversary.